A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Name: A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Published: 2015
License: Public Domain

Infinity Pharmaceuticals, Inc. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

non-small-cell-lung-cancer

advanced solid tumors (part a/b/c/d), non-small cell lung cancer (part e), melanoma (part e), squamous cell cancer of the head and neck (part e), triple negative breast cancer (part f), adrenocortical carcinoma (part g), mesothelioma (part g), high-circulating myeloid-derived suppressor cells (part h), ipi-549, phase 1, advanced solid tumor, non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 905067
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.